| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0009 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |